Nuclear medicine start-up International Isotopes of Denton, TX, has formed alliances with several universities and institutions as part of the company's plan to develop a U.S. source for radioisotopes used for medical purposes (SCAN 9/3/97). The firm
Nuclear medicine start-up International Isotopes of Denton, TX, has formed alliances with several universities and institutions as part of the company's plan to develop a U.S. source for radioisotopes used for medical purposes (SCAN 9/3/97). The firm inked relationships with the University of Texas M.D. Anderson Health Sciences Center, the University of North Texas, the University of California's Lawrence Berkeley Laboratory, and Texas A&M University. The agreements will help International Isotopes develop linear accelerator technology to produce radiopharmaceuticals.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.